Concepedia

Marja Saarnilehto

MS

Statistics

Publications

6

Citations

499

H-Index

6

Active since

2009

Affiliations

Orion Corporation (Finland)(Current)

University of Helsinki

Orion Corporation (United Kingdom)

Marja Saarnilehto is an author at Orion Corporation (Finland) specializing in ion channel pharmacology, life sciences, and pharmacology.

Publications per year

2009–2014

6

Publications

6

Attenuation of Mechanical Hypersensitivity by an Antagonist of the TRPA1 Ion Channel in Diabetic Animals

Hong Wei, Minna M. Hämäläinen, Marja Saarnilehto et al. · Anesthesiology · 2009 · 155 citations · Full text

Medicine, Pharmacology, Physiology +17

Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: Sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy

Ari Koivisto, Mika Hukkanen, Marja Saarnilehto et al. · Pharmacological Research · 2011 · 130 citations

Medicine, Neurobiology, Neuroscience +14

Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the rat

Hong Wei, Ari Koivisto, Marja Saarnilehto et al. · Pain · 2011 · 95 citations

Life Sciences, Neuroscience, Pharmacology +17

Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic rat

Hong Wei, Hugh Chapman, Marja Saarnilehto et al. · Neuropharmacology · 2009 · 85 citations

Life Sciences, Neurobiology, Neuroscience +10

Contact sensitizer 2,4‐dinitrochlorobenzene is a highly potent human <scp>TRPA</scp>1 agonist

Marja Saarnilehto, Hugh Chapman, Terhi Savinko et al. · Allergy · 2014 · 24 citations

Life Sciences, Dermatology, Pharmacology +17

1–5 of 6